Publications by authors named "Murray B Urowitz"

Claim this Profile
D
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring.
Shivani Garg, Benoît Blanchet, Yann Nguyen, Fauzia Hollnagel, Ada Clarke, Murray B Urowitz

Arthritis Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics of Childhood-Onset Systemic Lupus Erythematosus.
Raffaella Carlomagno, Nicholas Gold, Fangming Liao, Jingjing Cao, Paul D Arnold, Murray B Urowitz

Arthritis Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.
Joo-Young Esther Lee, Arielle Mendel, Isabelle Malhamé, Megan R W Barber, Ann E Clarke, Murray B Urowitz

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents.
Anca D Askanase, Richard Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Murray B Urowitz

Rheumatol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional work disability from the perspectives of persons with systemic lupus erythematosus: a qualitative thematic analysis.
Behdin Nowrouzi-Kia, Aaron S Howe, Anson Li, Jeremy Tan, Natalia Saade-Cleves, Murray B Urowitz

Arthritis Res Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study.
Cynthia Aranow, Cornelia F Allaart, Zahir Amoura, Ian N Bruce, Patricia C Cagnoli, Murray B Urowitz

Ann Rheum Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Megan R W Barber, Manuel Francisco Ugarte-Gil, John G Hanly, Murray B Urowitz, Yvan St-Pierre

Ann Rheum Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations.
Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Murray B Urowitz

Lupus Sci Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus.
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz

Lupus Sci Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort.
Yann Nguyen, Benoît Blanchet, Murray B Urowitz, John G Hanly, Caroline Gordon

Arthritis Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease.
Matteo Piga, Kostantinos Tselios, Luísa Viveiros, Elisabetta Chessa, Ana Neves, Murray Barry Urowitz

Best Pract Res Clin Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosus.
Thai-Son Tang, Fangming Liao, Declan Webber, Nicholas Gold, Jingjing Cao, Murray B Urowitz

Rheumatology (Oxford)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling.
Ann E Clarke, John G Hanly, Murray B Urowitz, Yvan St Pierre, Caroline Gordon

Arthritis Care Res (Hoboken)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correspondence on "relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus" by Chi Chiu Mok et al.
Laura Whittall-Garcia, Dafna D Gladman, Murray B Urowitz, Zahi Touma, Sindhu R Johnson

Lupus· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Threshold Score for Classification of Systemic Lupus Erythematosus Using the EULAR/ACR Criteria.
Sindhu R Johnson, Juan P Diaz Martinez, Laura Whittall-Garcia, Murray B Urowitz, Dafna D Gladman

J Rheumatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated Neutropenia in Systemic Lupus Erythematosus.
Nouf A Alhammadi, Dafna D Gladman, Jiandong Su, Murray B Urowitz

J Rheumatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomes.
Laura Whittall-Garcia, Dafna D Gladman, Murray B Urowitz, Jiandong Su, Zahi Touma

Semin Arthritis Rheum· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
Murray B Urowitz, Cynthia Aranow, Yumi Asukai, Damon L Bass, Ian N Bruce

Arthritis Care Res (Hoboken)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic.
Francesca S Cardwell, Susan J Elliott, Ricky Chin, Yvan St Pierre, May Y Choi, Murray B Urowitz

Lupus Sci Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following antimalarial withdrawal in patients with quiescent systemic lupus erythematosus.
Danaë A Papachristos, Dafna D Gladman, Jiandong Su, Murray B Urowitz

Semin Arthritis Rheum· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria.
Ronald van Vollenhoven, Anca D Askanase, Andrew S Bomback, Ian N Bruce, Angela Carroll, Murray B Urowitz

Lupus Sci Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort.
John G Hanly, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Murray B Urowitz

Arthritis Rheumatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population.
Courtney Hardy, Dafna D Gladman, Jiandong Su, Nathalie Rozenbojm, Murray B Urowitz

Rheumatol Int· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus.
Konstantinos Tselios, Dafna D Gladman, Jiandong Su, Murray B Urowitz

ACR Open Rheumatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus.
Jagan Sivakumaran, Paula Harvey, Ahmed Omar, Oshrat Tayer-Shifman, Murray B Urowitz

Lupus Sci Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis